Skip to Main Content

Utah-based Intermountain Healthcare and the Icelandic company deCODE Genetics are teaming up on a deep dive into the DNA of half a million patients, a collaboration they hope can reveal connections between the makeup of our genomes and our health.

The partnership, announced Wednesday and dubbed the HerediGene: Population Study, aims to analyze the genomes of 500,000 patients from Intermountain’s network of clinics and hospitals in Utah and Idaho. Scientists and clinical experts from deCODE and Intermountain will compare the genomic data with patients’ medical histories to gain a better understanding of how our genes influence our health.

advertisement

For deCODE, a subsidiary of Amgen, the project could also point to future therapeutics.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED